Main menu

Oxford Nanopore at the Annual Cancer Research Meeting

Chicago, Illinois, United States

The annual cancer research meeting is the critical driver of progress against cancer, the place where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share and discuss the latest breakthroughs. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; this meeting showcases cutting-edge cancer science and medicine.

Meet the Oxford Nanopore team at Booth 1553 in the exhibit hall, and will host an Exhibitor Spotlight Theater Monday, April 28th, 2025. See session details below.

Unlock Transformative Cancer Insights: The power of ultra-rich nanopore sequencing

Join us to explore how nanopore sequencing enables the integration of multiomic molecular information to deepen our understanding of cancer biology and pave the way for more precise diagnostics in the future.

In this session, you will learn how Dr. Debarshi Mustafi, professor of ophthalmology at the UW School of Medicine is using nanopore sequencing to determine parent of origin in Retinoblastoma, which is associated with different disease trajectories.

Later, hear how Dr. Gabriel Griffin, Principal Investigator at the Dana-Farber Cancer Institute and Harvard Medical School, is leveraging direct DNA methylation sequencing to create a rapid epigenomic classifier for Acute Myeloid Leukemia. This Exhibitor Spotlight Theater is a promotional activity and is not approved for continuing education credit.

This Exhibitor Spotlight Theater is a promotional activity and is not approved for continuing education credit. The content of this Exhibitor Spotlight Theater and opinions expressed by presenters are those of the sponsor or presenter and are not of the American Association for Cancer Research; (AACR®).

Date: Monday, April 28th

Time: 12:30 pm - 1:30 pm CT

Location: Spotlight Theater C

Symposium recordings

Prognostic importance of direct assignment of parent-of-origin via long-read genome and epigenome sequencing in retinoblastoma

Debarshi Mustafi, University of Washington

Rapid epigenomic classification of acute leukemia

Gabriel Griffin, Dana-Farber Cancer Institute

Spotlight Theater speakers

On-booth activities

Booth 1553
Booth 1553

Sunday, April 27th

Monday, April 28th

Tuesday, April 29th

Wednesday, April 30th

10:15 am — Characterising genomic and epigenomic variants in tumour-normal research samples with Oxford Nanopore EPI2ME analysis workflow

Sergey Aganezov, Oxford Nanopore Technologies

10:15 am — Characterising genomic and epigenomic variants in tumour-normal research samples with Oxford Nanopore EPI2ME analysis workflow

Sergey Aganezov, Oxford Nanopore Technologies

11:30 am — Flow cell loading/initiating a sequencing run

Maddy Hartley, Oxford Nanopore Technologies

11:30 am — Flow cell loading/initiating a sequencing run

Maddy Hartley, Oxford Nanopore Technologies

12:30 pm — Uncover novel cancer biology with scRNAseq and long-read sequencing

Patrick Murphy, Oxford Nanopore Technologies

3:00 pm — Flow cell loading/initiating a sequencing run

Maddy Hartley, Oxford Nanopore Technologies

3:00 pm — Comprehensive multi-omic data from a single assay with the Oxford Nanopore Hereditary Cancer Panel

Rob King, Oxford Nanopore Technologies

3:00 pm — Beyond bisulfite conversion: Rapid, real-time tumor methylation profiling via direct DNA sequencing

Claire Attwooll, Oxford Nanopore Technologies

入門

MinION Starter Packを購入 ナノポア製品の販売 シークエンスサービスプロバイダー グローバルディストリビューター

お問い合わせ

Intellectual property Cookie policy Corporate reporting Privacy policy Terms & conditions Accessibility

Oxford Nanoporeについて

Contact us 経営陣 メディアリソース & お問い合わせ先 投資家向け Oxford Nanopore社で働く BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Japanese flag